Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IPHA Innate Pharma > Main Composition
IPHA Innate Pharma
2.190
-0.100-4.37%
All
YOY
Do not show
Business Unit:EUR
nameYOYOperating income%
Single segment--24.7M100.00%
Region Unit:EUR
nameYOYOperating income%
France--24.7M100.00%
Company Overview More
Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Its product pipeline include Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Herv? Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fourni?, and Fran鏾is Romagn? on September 23, 1999 and is headquartered in Marseille, France.
CEO: Dr. Mondher Mahjoubi, M.D.
Market: NASDAQ
Listing Date: 10/17/2019
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist